BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 23.09.2020

Draft Guidance for Cannabidiol; Draft Guidance for Industry; Availability

The Food and Drug Administration (FDA, Agency, or we) is announcing the availability of a draft guidance for industry, entitled "Draft Guidance for Cannabidiol." The draft guidance, when finalized, will provide product-specific recommendations on, among other things, the information and data needed to demonstrate bioequivalence (BE) to support abbreviated new drug applications (ANDAs) for cannabidiol oral solution.

Source: Federal Register — Food and Drug AdministrationOpen original release →